Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancer Symposium: Low Middle- Income Countries vs. High- Income Countries: Cancer Care

Share :

ASCO Direct Highlights™ 2022 Miami Symposium

8 - 9 Jul 2022
Published: 26 Jul 2021
Views: 37
Rating:
Save
Dr Julie Gralow / Dr Eduardo Cazap / Dr Luis Raez

Related Videos

Hope vs Hype of evidence interpretation
Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India
Hope vs Hype of evidence interpretation ( Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India )
7 Nov 2023
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Carolyn Taylor - Executive Director, Global Focus on Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )
5 Sep 2023
ASCO's efforts to improve global cancer care through the years
Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru
ASCO's efforts to improve global cancer care through the years ( Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru )
9 Jun 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Interpreting statistics in clinical trials
Dr Sudeep Gupta - Tata Medical Centre, Mumbai, India
Interpreting statistics in clinical trials ( Dr Sudeep Gupta - Tata Medical Centre, Mumbai, India )
19 Sep 2022
Defining Value in Indian healthcare: Asking the right questions
Dr Kumar Prabhash - Tata Memorial Hospital, Mumbai, India
Defining Value in Indian healthcare: Asking the right questions ( Dr Kumar Prabhash - Tata Memorial Hospital, Mumbai, India )
18 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation